• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于癌症基因组图谱和广西队列研究C-X-C基序趋化因子配体1在结肠腺癌中的诊断及预后价值

Diagnosis and prognostic value of C-X-C motif chemokine ligand 1 in colon adenocarcinoma based on The Cancer Genome Atlas and Guangxi cohort.

作者信息

Gong Yi-Zhen, Ma Hui, Ruan Guo-Tian, Zhu Li-Chen, Liao Xi-Wen, Wang Shuai, Yan Ling, Huang Wei, Huang Ke-Tuan, Xie Hailun, Zhu Guang-Zhi, Wang Xiang-Kun, Liao Cun, Gao Feng

机构信息

Department of Colorectal and Anal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China.

Department of Immunology, School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China.

出版信息

J Cancer. 2021 Jul 25;12(18):5506-5518. doi: 10.7150/jca.51524. eCollection 2021.

DOI:10.7150/jca.51524
PMID:34405013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8364656/
Abstract

The objective was to identify and validate C-X-C motif chemokine ligand 1() for diagnosis and prognosis in colon adenocarcinoma (COAD). Our current study had enrolled one The Cancer Genome Atlas (TCGA) cohort and two Guangxi cohorts to identify and verify the diagnostic and prognostic values of in COAD. Functional enrichment was performed by gene set enrichment analysis (GSEA). In TCGA cohort, the expression of was significantly up-regulated in tumor tissues and decreased as the tumor stage developed. The receiver operating characteristic (ROC) curve showed that had a high diagnostic value for COAD. The result of Kaplan-Meier survival analysis showed that gene expression (=0.045) was significantly correlated with overall survival (OS) of COAD. Results of Guangxi cohort also verified the diagnostic value of in COAD, and sub-group survival analyses also suggested that patients with high expression were related to a favorable OS (Corrected =0.005). GSEA revealed that high expression phenotype was related to cytokine activity, cell apoptosis, regulation pathway, and regulation of autophagy in COAD. In this study, we found that gene might be a potential diagnostic biomarker for COAD, and might serve as a prognostic biomarker for specific subgroup of COAD.

摘要

目的是鉴定并验证C-X-C基序趋化因子配体1()在结肠腺癌(COAD)诊断和预后中的作用。我们目前的研究纳入了一个癌症基因组图谱(TCGA)队列和两个广西队列,以鉴定并验证其在COAD中的诊断和预后价值。通过基因集富集分析(GSEA)进行功能富集。在TCGA队列中,其在肿瘤组织中的表达显著上调,并随着肿瘤分期的发展而降低。受试者工作特征(ROC)曲线显示,其对COAD具有较高的诊断价值。Kaplan-Meier生存分析结果显示,基因表达(=0.045)与COAD的总生存期(OS)显著相关。广西队列的结果也验证了其在COAD中的诊断价值,亚组生存分析还表明,高表达患者的OS较好(校正后=0.005)。GSEA显示,高表达表型与COAD中的细胞因子活性、细胞凋亡、调控途径和自噬调控有关。在本研究中,我们发现基因可能是COAD的潜在诊断生物标志物,并可能作为COAD特定亚组的预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b527/8364656/005a086e2917/jcav12p5506g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b527/8364656/9ba3242211fc/jcav12p5506g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b527/8364656/a1711e836259/jcav12p5506g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b527/8364656/c2f4857487db/jcav12p5506g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b527/8364656/a6530005b743/jcav12p5506g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b527/8364656/eaddc055540c/jcav12p5506g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b527/8364656/d2e4b49af61f/jcav12p5506g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b527/8364656/005a086e2917/jcav12p5506g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b527/8364656/9ba3242211fc/jcav12p5506g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b527/8364656/a1711e836259/jcav12p5506g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b527/8364656/c2f4857487db/jcav12p5506g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b527/8364656/a6530005b743/jcav12p5506g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b527/8364656/eaddc055540c/jcav12p5506g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b527/8364656/d2e4b49af61f/jcav12p5506g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b527/8364656/005a086e2917/jcav12p5506g007.jpg

相似文献

1
Diagnosis and prognostic value of C-X-C motif chemokine ligand 1 in colon adenocarcinoma based on The Cancer Genome Atlas and Guangxi cohort.基于癌症基因组图谱和广西队列研究C-X-C基序趋化因子配体1在结肠腺癌中的诊断及预后价值
J Cancer. 2021 Jul 25;12(18):5506-5518. doi: 10.7150/jca.51524. eCollection 2021.
2
Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma.自然杀伤细胞组 2 成员 D 配体在结肠腺癌中的临床意义和前景的研究与验证。
Aging (Albany NY). 2021 Apr 27;13(9):12565-12586. doi: 10.18632/aging.202935.
3
Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis.免疫 ULBP1 在结肠腺癌中升高并可预测预后。
Front Genet. 2022 Feb 8;13:762514. doi: 10.3389/fgene.2022.762514. eCollection 2022.
4
INSC Is Down-Regulated in Colon Cancer and Correlated to Immune Infiltration.INSC在结肠癌中表达下调并与免疫浸润相关。
Front Genet. 2022 May 19;13:821826. doi: 10.3389/fgene.2022.821826. eCollection 2022.
5
Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.铁死亡相关基因特征在结肠腺癌中的预后意义
World J Clin Cases. 2021 Oct 16;9(29):8671-8693. doi: 10.12998/wjcc.v9.i29.8671.
6
Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma.整合素 α 亚家族 mRNA 表达在结肠腺癌中的诊断和预后价值。
Oncol Rep. 2019 Sep;42(3):923-936. doi: 10.3892/or.2019.7216. Epub 2019 Jun 28.
7
Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.m5C相关调控因子在结肠腺癌预后中的潜在作用探索
Front Genet. 2022 Feb 24;13:816173. doi: 10.3389/fgene.2022.816173. eCollection 2022.
8
LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma.长链非编码 RNA ALMS1-IT1 是结直肠腺癌的一种新型预后生物标志物,并与免疫浸润相关。
Medicine (Baltimore). 2022 Oct 21;101(42):e31314. doi: 10.1097/MD.0000000000031314.
9
High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma.高 MICAL-L2 表达及其在结肠腺癌预后中的作用。
BMC Cancer. 2022 May 2;22(1):487. doi: 10.1186/s12885-022-09614-0.
10
Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an ERK-dependent manner.CXCL3 在结肠癌中的高表达以 ERK 依赖的方式促进肿瘤细胞的恶性行为。
BMC Cancer. 2023 Nov 29;23(1):1162. doi: 10.1186/s12885-023-11655-y.

引用本文的文献

1
Identification and validation of a prognostic signature based on six immune-related genes for colorectal cancer.基于六个免疫相关基因的结直肠癌预后标志物的鉴定与验证
Discov Oncol. 2024 May 28;15(1):192. doi: 10.1007/s12672-024-01058-1.
2
Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.趋化因子作为结直肠癌患者的预后因素:系统评价和荟萃分析。
Int J Mol Sci. 2024 May 15;25(10):5374. doi: 10.3390/ijms25105374.
3
Inflammation-related molecular signatures involved in the anticancer activities of brigatinib as well as the prognosis of EML4-ALK lung adenocarcinoma patient.

本文引用的文献

1
RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression.RIP3 通过控制肿瘤细胞增殖和 CXCL1 诱导的免疫抑制促进结肠炎相关结直肠癌。
Theranostics. 2019 Jun 2;9(12):3659-3673. doi: 10.7150/thno.32126. eCollection 2019.
2
Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.SMAD4 缺失通过 CXCL1/8-CXCR2 轴招募肿瘤相关中性粒细胞促进结直肠癌进展。
Clin Cancer Res. 2019 May 1;25(9):2887-2899. doi: 10.1158/1078-0432.CCR-18-3684. Epub 2019 Jan 31.
3
CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
涉及 brigatinib 抗癌活性以及 EML4-ALK 肺腺癌患者预后的炎症相关分子特征。
Acta Pharmacol Sin. 2024 Jun;45(6):1252-1263. doi: 10.1038/s41401-024-01230-x. Epub 2024 Feb 15.
4
The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers.CXCL1 趋化因子在胃肠道癌中的临床意义和作用。
Cells. 2023 May 17;12(10):1406. doi: 10.3390/cells12101406.
CXC 趋化因子家族作为结直肠癌的预后或预测生物标志物及可能的药物靶点。
World J Gastroenterol. 2018 Nov 14;24(42):4738-4749. doi: 10.3748/wjg.v24.i42.4738.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
Interaction between Tumor-Associated Dendritic Cells and Colon Cancer Cells Contributes to Tumor Progression via CXCL1.肿瘤相关树突状细胞与结肠癌细胞的相互作用通过 CXCL1 促进肿瘤进展。
Int J Mol Sci. 2018 Aug 16;19(8):2427. doi: 10.3390/ijms19082427.
6
Dietary patterns derived from principal component analysis (PCA) and risk of colorectal cancer: a systematic review and meta-analysis.基于主成分分析(PCA)得出的饮食模式与结直肠癌风险:系统评价和荟萃分析。
Eur J Clin Nutr. 2019 Mar;73(3):366-386. doi: 10.1038/s41430-018-0234-7. Epub 2018 Jul 26.
7
Prognostic role of FUT8 expression in relation to p53 status in stage II and III colorectal cancer.FUT8 表达与 p53 状态在 II 期和 III 期结直肠癌中的预后作用。
PLoS One. 2018 Jul 5;13(7):e0200315. doi: 10.1371/journal.pone.0200315. eCollection 2018.
8
Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer.趋化因子(C-X-C 基序)配体 1 与结直肠癌患者的肿瘤进展和预后不良相关。
Biosci Rep. 2018 Jul 2;38(4). doi: 10.1042/BSR20180580. Print 2018 Aug 31.
9
Clinical Utility of Analyzing Circulating Tumor DNA in Patients with Metastatic Colorectal Cancer.分析转移性结直肠癌患者循环肿瘤 DNA 的临床实用性。
Oncologist. 2018 Nov;23(11):1310-1318. doi: 10.1634/theoncologist.2017-0621. Epub 2018 Apr 26.
10
DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis.DNA 修复蛋白 XPA 在结直肠癌中表达差异,并预测更好的预后。
Cancer Med. 2018 Jun;7(6):2339-2349. doi: 10.1002/cam4.1480. Epub 2018 Apr 19.